You sales reps are deluded self-important bunch of zeroes. You don't even see your physicians or hospitals anymore and can't pretend that you have any influence on the sales of the products like the good old days when your customers actually let you in their offices so you could buy their business. The sales of the jnj products would continue without your sorry lazy butts at home in your pjs faking your calls. You are an overpaid joke and it will be a shock to your system when the company realizes your real worth and lays you all off and you have to get a real job in the real world. Jnj is run by a bunch of clowns to have so many slackers in the field doing nothing all day long.
You sales reps are deluded self-important bunch of zeroes. You don't even see your physicians or hospitals anymore and can't pretend that you have any influence on the sales of the products like the good old days when your customers actually let you in their offices so you could buy their business. The sales of the jnj products would continue without your sorry lazy butts at home in your pjs faking your calls. You are an overpaid joke and it will be a shock to your system when the company realizes your real worth and lays you all off and you have to get a real job in the real world. Jnj is run by a bunch of clowns to have so many slackers in the field doing nothing all day long.
Anonymous
Guest
Anonymous
Guest
Sounds like someone got canned and is a little resentful. Jnj is a fabulous company and the OP is just fishing to see if it will stick. Go somewhere else because we are not looking to publish inaccuracies. If you are bitter and the stories you are talking about are outlandish then try to see what sticks on another board or company. There are always a few than make the whole look bad and it sounds like you were a gem in that category. I will pray for you.
All missing the point - you can't even get quality product out the door. You - or at least McNeil - are anything but 'fabulous' to the millions of patients and consumers who used to trust your brands....yet still delusional about keeping Fort Washington site open and Weldon as CEO...how many more recalls before there is accountability or at least some humility...fabulous indeed.
Anonymous
Guest
Anonymous
Guest
Been with the company for years. Never heard anyone doing this. You must know some real assholes and must be an asshole yourself.
Unless you have been living under a rock, everyone knows that this is common practice in Pharma. Anyone see CNN tonight??? The Doctors are just as bad, if not worse!! You can call HR all you want but 9 times out of 10, they do nothing. It is a sad state of affairs but the Pharmaceutical companies have created this monster and the public is now just finding out how bad it is.
Anonymous
Guest
Anonymous
Guest
ha, ha, ha.
listen sweetheart, since the OP is obviously a woman, don't get your panties in a hiss over a few reps out there who get a free sandwich every now and then from their loyal catering company. thats just business. do you not think that there are bigger fish to fry, aka, exects, presidents, vp's, etc.....ever hear of Enron?
its the business world doll, and you chose to be a part of it.
if you don't like it, get out, but to generalize that every rep and manager of cheating the copmany leads me to believe that you dont need the stress in your life and should go do something else. life is too short.
good luck.
listen sweetheart, since the OP is obviously a woman, don't get your panties in a hiss over a few reps out there who get a free sandwich every now and then from their loyal catering company. thats just business. do you not think that there are bigger fish to fry, aka, exects, presidents, vp's, etc.....ever hear of Enron?
its the business world doll, and you chose to be a part of it.
if you don't like it, get out, but to generalize that every rep and manager of cheating the copmany leads me to believe that you dont need the stress in your life and should go do something else. life is too short.
good luck.
Anonymous
Guest
Anonymous
Guest
To the OP, based on your writing style, it is obvious that you have posted on the JNJ/Cafepharma forum numerous times. You've also written that you still work for JNJ but not in the field. Based on the times and dates of your posting, a lot of them are during normal business hours. You complain that the JNJ reps are stealing from the company, however I wonder how your boss would feel if he/she knew that you waste the company's money during the day by surfing the web and posting on cafepharma during normal business hours?
Anonymous
Guest
Anonymous
Guest
All the j&j biotech and pharma reps and managers are ripping off the company. They are using the company credit cards under false pretenses and are criminally getting thousands of dollars in catered food, office supplies, gifts, expensive dinners, parking garages, postage, etc paid for their personal use and their families. When will this blatant criminal activity end? Knowing what is really going on in the field makes me furious. With all the consultants J&J pays millions for the company has absolutely no clue that the reps and managers are in cahoots and are not even leaving their houses to to go to work and instead are illegally charging millions of dollars on the corporate card and getting reimbursed. Yet J&J only rewards these crooks and criminals with job stability, pay raises, and larger expense accounts to steal from. Things will be exposed very soon to the public if J&J doesn't wake up and look after the sharholder's investments in the company and begin cutting costs appropriately. I'm sick of the money wasted and stolen in the field and know if reps and managers are finally not held accountable for not working and stealing from the company that the truth will be exposed pubicly and J&J will suffer the consequences of mismanaging their shareholders funds. Only the people who work in this industry know of the true criminal activity going on with the J&J employees. All will be exposed if J&J doesn't clean up it's employees and get rid of the lazy criminal reps and managers.
Sorry you got fired. It sucks doesn't it? McDonalds is open on Thanksgiving, yum I hear the $1 menu is delicious. Its great to have this great job this thanksgiving. Can you say, canned?
Anonymous
Guest
Anonymous
Guest
to the OP (who obviously has a thorn up his a**): with all your long winded BS, you claim everybody did it including you and your managers in cahoots, and you claim you're so appaled by it, and YOU NEVER BLEW THE WHISTLE OR EVEN CALLED HR? I call BULLSHIT. Maybe you're on a guilt trip trying to drag everyone else down to your level.
I got fired and am mad as hell that no one will hire me. It sucks to not have a turkey on thanksgiving. I have some frozen salad.
Anonymous
Guest
Anonymous
Guest
To the OP, based on your writing style, it is obvious that you have posted on the JNJ/Cafepharma forum numerous times. You've also written that you still work for JNJ but not in the field. Based on the times and dates of your posting, a lot of them are during normal business hours. You complain that the JNJ reps are stealing from the company, however I wonder how your boss would feel if he/she knew that you waste the company's money during the day by surfing the web and posting on cafepharma during normal business hours?
Dude, you can't possibly think that there's only one person who works in house at jnj who knows the real dirt on what's going out in the field in all the operating companies and is the only one mentioning it on cafepharma, do you? All my coworkers are disgusted after any meeting or poa when we hear the real deal straight from the horses mouths once the reps big mouths come in contact with the first drop of liquid truth at the bars each night. Because I have a vested interest in this company having had been here for several years I believe it's my duty and right to express my concern on the company's forums at whatever time I have a 5-minute break in my workday. As for my boss, he hears all about you lazy criminal reppies at the meetings too and couldn't be more disgusted at what people in the field are getting away with. Tool.
Anonymous
Guest
Anonymous
Guest
Think about it this way, we are an army! Some go into battle like true heros to face the challenges (sales reps) while you wait at home base (HO) to hear the results but never fight a day. Now go grab your boss a drink and snack from that free vending machines a H.O.
Anonymous
Guest
Anonymous
Guest
Think about it this way, we are an army! Some go into battle like true heros to face the challenges (sales reps) while you wait at home base (HO) to hear the results but never fight a day. Now go grab your boss a drink and snack from that free vending machines a H.O.
Hate to break it to you, but I wouldn't exactly call watching cartoons and daytime talk shows in your pjs and entering fake doctor calls while your wife uses the company car monday through friday to make errands going into battle, dude!
Anonymous
Guest
Anonymous
Guest
Don't need an exit strategy from Pharma Sales? Better get one! Check this out!
--------------------------------------------------------------------------------
The future of the field-based rep will be more of a medical-liason type (RN, NP, PA, PharmD, or PhD) working in conjunction with contracting teams. There will be fewer and fewer reps each year. There's not a lot of selling in this industry anymore as legal has stepped in and put a stop to it. The Physician Payment Sunshine Act kicks in 2012 which means no more lunches, speakers, etc. There's really no role for sales reps anymore except busy nonsense paperwork. Sales in pharma/biotech is a dying profession.
Its over folks, the iceberg is in full view. You'd better start reaching for your career lifeboats, because the sinking of the "SS Drug Rep Profession" is inevitable; and that means everybody, even you Mr./Ms Almighty "Biotech rep". Once you're on the street, you will be treated 100% the same as PC reps; no more high and mighty.
--------------------------------------------------------------------------------
The future of the field-based rep will be more of a medical-liason type (RN, NP, PA, PharmD, or PhD) working in conjunction with contracting teams. There will be fewer and fewer reps each year. There's not a lot of selling in this industry anymore as legal has stepped in and put a stop to it. The Physician Payment Sunshine Act kicks in 2012 which means no more lunches, speakers, etc. There's really no role for sales reps anymore except busy nonsense paperwork. Sales in pharma/biotech is a dying profession.
Its over folks, the iceberg is in full view. You'd better start reaching for your career lifeboats, because the sinking of the "SS Drug Rep Profession" is inevitable; and that means everybody, even you Mr./Ms Almighty "Biotech rep". Once you're on the street, you will be treated 100% the same as PC reps; no more high and mighty.
Anonymous
Guest
Anonymous
Guest
Unless you have been living under a rock, everyone knows that this is common practice in Pharma. Anyone see CNN tonight??? The Doctors are just as bad, if not worse!! You can call HR all you want but 9 times out of 10, they do nothing. It is a sad state of affairs but the Pharmaceutical companies have created this monster and the public is now just finding out how bad it is.
Checkout this article featuring Joe McCracken, vice president of business development at Genentech, in which he makes the following assessment:
"At a recent conference, McCracken questioned how much longer pharma will pay sales reps to bring coffee and donuts into clinics. He also predicted that the future pharma sales model will be less focused on detailing more focused on running call centers to help patients with reimbursement."
Here is a link to the full article: http://www.bnet.com/blog/pharma/more...cal-sales/5707
The bottomline is that whether you are PC, Oncology, etc, there is no long term future in biopharma sales, as we know it. If you are not taking advantage of tuition reimbursement, etc, and developing a real exit strategy from this industry, or at least planning a transition to a ne career within the industry, you have your head deeply buried in the sand.
Anonymous
Guest
Anonymous
Guest
ha, ha, ha.
listen sweetheart, since the OP is obviously a woman, don't get your panties in a hiss over a few reps out there who get a free sandwich every now and then from their loyal catering company. thats just business. do you not think that there are bigger fish to fry, aka, exects, presidents, vp's, etc.....ever hear of Enron?
its the business world doll, and you chose to be a part of it.
if you don't like it, get out, but to generalize that every rep and manager of cheating the copmany leads me to believe that you dont need the stress in your life and should go do something else. life is too short.
good luck.
Sorry pal but I am the OP and am all man. Just fed up with all the bs going on in the field that the HO has to deal with. You reppie clowns are a bunch of lazy posers who show your true colors once you kick back a brewsky at the bar at meetings and poas. Sick of cleaning up the messes of corrupt reps and managers. It's not stress my man it's disgust. Thug reps and managers will be getting their just desserts real soon so we in the HO won't have to deal with their crap anymore.
Anonymous
Guest
Anonymous
Guest
Sorry pal but I am the OP and am all man. Just fed up with all the bs going on in the field that the HO has to deal with. You reppie clowns are a bunch of lazy posers who show your true colors once you kick back a brewsky at the bar at meetings and poas. Sick of cleaning up the messes of corrupt reps and managers. It's not stress my man it's disgust. Thug reps and managers will be getting their just desserts real soon so we in the HO won't have to deal with their crap anymore.
Ha Ha! And I'm sitting here in front of my humungous HDTV basking in the huge bonus I just got at COBI. Heard I set a new record, dude, one that will stand for a long time.
It's gonna be a sweet Xmas for me!
Anonymous
Guest
Anonymous
Guest
Analysis: Pharma's woes not over, more restructuring seen
By Esha Dey
NEW YORK | Sun Nov 28, 2010 9:52pm IST
NEW YORK (Reuters) - Global drugmakers have cut tens of thousands of jobs ahead of patent expirations on their top-selling products, and the pain is not yet over.
Divisions across these companies -- from sales to research to manufacturing -- are still seen as vulnerable to additional cuts. Marketing expenses will likely continue to be slashed the most heavily.
"We will see even more restructuring as we near the patent cliff ... selling, general and administrative expenses will take the hardest hits, also manufacturing and research and development," Morningstar analyst Damien Conover said.
He estimated additional cuts of up to 2 percent of company workforces, saying "every major pharma will keep doing it."
The vast sales forces for major drugs going off patent, such as Pfizer Inc's cholesterol fighter Lipitor, are among the most obvious targets for job cuts.
According to a survey by consultant Challenger, Gray & Christmas, more than 45,000 job cuts were announced by the pharmaceutical industry this year through October, outpaced only by government agencies and nonprofit organizations.
More recently, Switzerland's Roche Holding AG announced plans to cut 4,800 jobs, or 6 percent of its workforce, over the next two years.
Novartis said it sought additional cost cuts in manufacturing, marketing and procurement, but dismissed reports that it was readying huge layoffs to do so.
A rolling wave of restructuring reflects the lack of major new drug launches to offset looming generic competition to multibillion-dollar medicines like Sanofi-Aventis and Bristol-Myers Squibb's drug Plavix for blood clots and Merck's Singulair for asthma.
While concerns over the "patent cliff" have dogged the industry for several years, in some cases the entry of generic versions of brand-name drugs has picked up more quickly than Wall Street had anticipated.
The entry of generics can cause branded drugs to quickly lose at least 80 percent of U.S. sales, but can be 90 percent or more once multiple generics are available.
In their latest quarter, Pfizer, AstraZeneca, Eli Lilly, GlaxoSmithKline and Roche reported sales that were hurt by generics and their shares fell, signaling their valuations may not have the patent loss impact fully baked in.
Most major drugmakers' shares have been on a downward trend since, with the Arca Pharmaceuticals Index down 4.6 percent since October 20, compared with a 1.9 percent rise for the broader Standard & Poor's 500 Index.
"The patent cliff was expected, but the rate of penetration of generics has been much higher than what anybody imagined," Deutsche Bank analyst Barbara Ryan said.
PATENT CLIFF JOURNEY
According to pharmaceutical market information company IMS Health, four large pharma companies -- AstraZeneca, Lilly, Boehringer Ingelheim and Bayer AG -- as of the end of 2009, had progressed less than one-third of the way through the patent cliff that runs from 2005 through 2014.
"There is more restructuring to be done ... large pharma, on an aggregate, is 40 percent of its way through with the patent cliff journey," IMS Health analyst Murray Aitken said at the Reuters Health Summit earlier this month.
IMS projects generic penetration could reach 85 percent by 2014.
Drugmakers are also facing greater pricing pressure due to more recent developments, such as a new U.S. healthcare law and price controls in European countries. That raises the need for innovative drugs that generate bigger volumes, if not the sky-high margins of past treatments.
"Low productivity of internal research and development has rendered the drugmakers inadequately prepared for the patent cliff," Argus Research Co analyst Patrick Cheng said.
AstraZeneca, which reported a 4 percent drop in quarterly sales late last month, said it was not done with cost cuts.
"You'll continue to see us reallocate marketing and sales resources," Astra CEO David Brennan told the Reuters Health Summit.
Germany's Bayer also announced a cost- and job-cut plan, and Pfizer recently said it expects to exceed its original target of a 15 percent workforce reduction related to its $67 billion purchase of rival Wyeth.
Many analysts say drugmakers have no choice but to get even leaner, though research and innovation are essential in the long run.
"Most of these big companies have a lot of middle management; that is one area that they could focus on for further savings," Hapoalim Securities analyst Jon Lecroy said.
At the same time, cost cuts alone is not a strong sell when it comes to Wall Street.
"The industry is still trying to cost cut its way to intermediate terms of success," Fred Frank, a biotechnology banker and vice chairman of investment advisory firm Peter J. Solomon Co said, adding that was not a sustainable trend.
"Earnings don't produce revenue. Revenue produces earnings," he said.
(Reporting by Esha Dey; Editing by Michele Gershberg and Tim Dobbyn)
By Esha Dey
NEW YORK | Sun Nov 28, 2010 9:52pm IST
NEW YORK (Reuters) - Global drugmakers have cut tens of thousands of jobs ahead of patent expirations on their top-selling products, and the pain is not yet over.
Divisions across these companies -- from sales to research to manufacturing -- are still seen as vulnerable to additional cuts. Marketing expenses will likely continue to be slashed the most heavily.
"We will see even more restructuring as we near the patent cliff ... selling, general and administrative expenses will take the hardest hits, also manufacturing and research and development," Morningstar analyst Damien Conover said.
He estimated additional cuts of up to 2 percent of company workforces, saying "every major pharma will keep doing it."
The vast sales forces for major drugs going off patent, such as Pfizer Inc's cholesterol fighter Lipitor, are among the most obvious targets for job cuts.
According to a survey by consultant Challenger, Gray & Christmas, more than 45,000 job cuts were announced by the pharmaceutical industry this year through October, outpaced only by government agencies and nonprofit organizations.
More recently, Switzerland's Roche Holding AG announced plans to cut 4,800 jobs, or 6 percent of its workforce, over the next two years.
Novartis said it sought additional cost cuts in manufacturing, marketing and procurement, but dismissed reports that it was readying huge layoffs to do so.
A rolling wave of restructuring reflects the lack of major new drug launches to offset looming generic competition to multibillion-dollar medicines like Sanofi-Aventis and Bristol-Myers Squibb's drug Plavix for blood clots and Merck's Singulair for asthma.
While concerns over the "patent cliff" have dogged the industry for several years, in some cases the entry of generic versions of brand-name drugs has picked up more quickly than Wall Street had anticipated.
The entry of generics can cause branded drugs to quickly lose at least 80 percent of U.S. sales, but can be 90 percent or more once multiple generics are available.
In their latest quarter, Pfizer, AstraZeneca, Eli Lilly, GlaxoSmithKline and Roche reported sales that were hurt by generics and their shares fell, signaling their valuations may not have the patent loss impact fully baked in.
Most major drugmakers' shares have been on a downward trend since, with the Arca Pharmaceuticals Index down 4.6 percent since October 20, compared with a 1.9 percent rise for the broader Standard & Poor's 500 Index.
"The patent cliff was expected, but the rate of penetration of generics has been much higher than what anybody imagined," Deutsche Bank analyst Barbara Ryan said.
PATENT CLIFF JOURNEY
According to pharmaceutical market information company IMS Health, four large pharma companies -- AstraZeneca, Lilly, Boehringer Ingelheim and Bayer AG -- as of the end of 2009, had progressed less than one-third of the way through the patent cliff that runs from 2005 through 2014.
"There is more restructuring to be done ... large pharma, on an aggregate, is 40 percent of its way through with the patent cliff journey," IMS Health analyst Murray Aitken said at the Reuters Health Summit earlier this month.
IMS projects generic penetration could reach 85 percent by 2014.
Drugmakers are also facing greater pricing pressure due to more recent developments, such as a new U.S. healthcare law and price controls in European countries. That raises the need for innovative drugs that generate bigger volumes, if not the sky-high margins of past treatments.
"Low productivity of internal research and development has rendered the drugmakers inadequately prepared for the patent cliff," Argus Research Co analyst Patrick Cheng said.
AstraZeneca, which reported a 4 percent drop in quarterly sales late last month, said it was not done with cost cuts.
"You'll continue to see us reallocate marketing and sales resources," Astra CEO David Brennan told the Reuters Health Summit.
Germany's Bayer also announced a cost- and job-cut plan, and Pfizer recently said it expects to exceed its original target of a 15 percent workforce reduction related to its $67 billion purchase of rival Wyeth.
Many analysts say drugmakers have no choice but to get even leaner, though research and innovation are essential in the long run.
"Most of these big companies have a lot of middle management; that is one area that they could focus on for further savings," Hapoalim Securities analyst Jon Lecroy said.
At the same time, cost cuts alone is not a strong sell when it comes to Wall Street.
"The industry is still trying to cost cut its way to intermediate terms of success," Fred Frank, a biotechnology banker and vice chairman of investment advisory firm Peter J. Solomon Co said, adding that was not a sustainable trend.
"Earnings don't produce revenue. Revenue produces earnings," he said.
(Reporting by Esha Dey; Editing by Michele Gershberg and Tim Dobbyn)
Anonymous
Guest
Anonymous
Guest
I'm retired from jnj with over thirty-plus years of experience in this industry. I've seen this career go from a once honored profession where physicians actually looked forward to seeing a representative from a company in their office. You simply put your card in and were told the doctor would you see in a few minutes. The reason they saw you was that you were professional, trustworthy, knowledgeable, and presented information that was of use to them in making professional decisions regarding patients. Today, they don't need you because you really don't have any information they can't get already, insurance companies dictate what can be prescribed, and you take too much of their time when they could be seeing a patient and getting paid for it. They take your lunch because it's a benefit for their staff. It's a break for them, and the last thing they want to hear is a presentation from your mouth. You have no credibility with the physician because of the training you have been given. Telling a fifty year old physician how to treat a patient, coming from someone in their twenties has no credibility at all. They all know that what you're there for is to get a "signature", and offics are more than glad to get that for you just to get you out of their office so they can treat the patients who really need the doctors attention.
This is sad, but not true. You absolutely provide no value to offices anymore, not even providing samples, because patients expect to get these each time they come for a visit and this has itself created a nightmare. As a patient now sitting in my doctors waiting room and observing the representatives who come to the offices makes me sad to see how this profession has been so cheapened. Your no longer needed or wanted.
This is sad, but not true. You absolutely provide no value to offices anymore, not even providing samples, because patients expect to get these each time they come for a visit and this has itself created a nightmare. As a patient now sitting in my doctors waiting room and observing the representatives who come to the offices makes me sad to see how this profession has been so cheapened. Your no longer needed or wanted.
Anonymous
Guest
Anonymous
Guest
I'm retired from jnj with over thirty-plus years of experience in this industry. I've seen this career go from a once honored profession where physicians actually looked forward to seeing a representative from a company in their office. You simply put your card in and were told the doctor would you see in a few minutes. The reason they saw you was that you were professional, trustworthy, knowledgeable, and presented information that was of use to them in making professional decisions regarding patients. Today, they don't need you because you really don't have any information they can't get already, insurance companies dictate what can be prescribed, and you take too much of their time when they could be seeing a patient and getting paid for it. They take your lunch because it's a benefit for their staff. It's a break for them, and the last thing they want to hear is a presentation from your mouth. You have no credibility with the physician because of the training you have been given. Telling a fifty year old physician how to treat a patient, coming from someone in their twenties has no credibility at all. They all know that what you're there for is to get a "signature", and offics are more than glad to get that for you just to get you out of their office so they can treat the patients who really need the doctors attention.
This is sad, but not true. You absolutely provide no value to offices anymore, not even providing samples, because patients expect to get these each time they come for a visit and this has itself created a nightmare. As a patient now sitting in my doctors waiting room and observing the representatives who come to the offices makes me sad to see how this profession has been so cheapened. Your no longer needed or wanted.
Wow, old timer. You must have been really great in your day, huh. Truth is that in many J&J divisions we are not sample droppers, caterers, or in our friggin twenties (with all the attrition, usually only the "best" are still standing, and many of them are 40-plus. Cheap is what you make it - there are a lot of professional reps out there that know how to bring value to customers. Sorry your Primary care profesional life didn't allow you to see what "bringing value" means. BTW - sorry to hear you have to sit around as a patient now and need the doc's attention. Off the payroll soon?
Anonymous
Guest
Anonymous
Guest
& you think your in sales, while along you realize you've been a walking billboard, an annoying commercial that interrupts people while they are working. Imagine you had to reply to 10 spam emails a day everyday everytime they show up, while your working. & it's the same friggen ones. Think about what you do, then think what a contract sale person does. Same thing if you ask me. Then ask yourself if you really had to secure a contract do you have the hutspa to get the business. Nope you ask someone to sign something to show some overpaid baby sitter that you worked. You just happened to make alot of money which somehow distorted your self esteem so much that you actually believe that there is something somehow different from a day to day perspective. Other then receiving a paycheck from another company. somehow I think you'll all be working for some contract company and realize it ain't much different. Im also an overpaid walking commercial for jnj who used to love the good times & the money that's tossed around and im gonna coast with my large paycheck and great bennies until they get rid of me.
Anonymous
Guest
Anonymous
Guest
Wow, old timer. You must have been really great in your day, huh. Truth is that in many J&J divisions we are not sample droppers, caterers, or in our friggin twenties (with all the attrition, usually only the "best" are still standing, and many of them are 40-plus. Cheap is what you make it - there are a lot of professional reps out there that know how to bring value to customers. Sorry your Primary care profesional life didn't allow you to see what "bringing value" means. BTW - sorry to hear you have to sit around as a patient now and need the doc's attention. Off the payroll soon?
Doesn't matter if you're middle aged, lazy and unmotivated (which all 40+ reps are), an old fart who is coasting until retirement (too many in this company to count), or a dumb recent college grad with a ba or bs (actually the best bang for the buck since their salary is more than half of the 40+ crew and they are much more attractive to look at than the old geezers and hags in the field). Anyone in this industry who "sells" consumer, pharma, and biotech products knows what a joke of a job a "detail person" is. The only true salespeople at jnj worth their weight are those whos salary is mostly commision-based like those of us at ethicon. We don't sell, we don't eat and we are FIRED immediately. I don't care how young or old you drug reps are but there is no value in your job, never was. And your customers don't respect you or your job. You are a laughingstock to the entire medical community and a waste of their time.
Anonymous
Guest
Anonymous
Guest
Doesn't matter if you're middle aged, lazy and unmotivated (which all 40+ reps are), an old fart who is coasting until retirement (too many in this company to count), or a dumb recent college grad with a ba or bs (actually the best bang for the buck since their salary is more than half of the 40+ crew and they are much more attractive to look at than the old geezers and hags in the field). Anyone in this industry who "sells" consumer, pharma, and biotech products knows what a joke of a job a "detail person" is. The only true salespeople at jnj worth their weight are those whos salary is mostly commision-based like those of us at ethicon. We don't sell, we don't eat and we are FIRED immediately. I don't care how young or old you drug reps are but there is no value in your job, never was. And your customers don't respect you or your job. You are a laughingstock to the entire medical community and a waste of their time.
You think that the 60 grand starting salary for recent college grads at Ethicon is mostly commission? What must an experienced ethicon rep make? Selling gastric bypass is not any more difficult than drugs. Don't kid yourself loser.